000			02904cam a22003617 4500
001			w23900
003			NBER
005			20211020104753.0
006			m o d
007			cr cnu||||||||
008			210910s2017 mau fo 000 0 eng d
100	1		_aHult, Kristopher J.
245	1	0	_aMeasuring the Potential Health Impact of Personalized Medicine: _bEvidence from MS Treatments / _cKristopher J. Hult.
260			_aCambridge, Mass. _bNational Bureau of Economic Research _c2017.
300			_a1 online resource: _billustrations (black and white);
490	1		_aNBER working paper series _vno. w23900
500			_aOctober 2017.
520	3		_aIndividuals respond to pharmaceutical treatments differently due to the heterogeneity of patient populations. This heterogeneity can make it difficult to determine how efficacious or burdensome a treatment is for an individual patient. Personalized medicine involves using patient characteristics, therapeutics, or diagnostic testing to understand how individual patients respond to a given treatment. Personalized medicine increases the health impact of existing treatments by improving the matching process between patients and treatments and by improving a patient's understanding of the risk of serious side effects. In this paper, I compare the health impact of new treatment innovations with the potential health impact of personalized medicine. I find that the impact of personalized medicine depends on the number of treatments, the correlation between treatment effects, and the amount of noise in a patient's individual treatment effect signal. For multiple sclerosis treatments, I find that personalized medicine has the potential to increase the health impact of existing treatments by roughly 50 percent by informing patients of their individual treatment effect and risk of serious side effects.
530			_aHardcopy version available to institutional subscribers
538			_aSystem requirements: Adobe [Acrobat] Reader required for PDF files.
538			_aMode of access: World Wide Web.
588	0		_aPrint version record
690		7	_aI1 - Health _2Journal of Economic Literature class.
690		7	_aI10 - General _2Journal of Economic Literature class.
690		7	_aI11 - Analysis of Health Care Markets _2Journal of Economic Literature class.
690		7	_aO3 - Innovation • Research and Development • Technological Change • Intellectual Property Rights _2Journal of Economic Literature class.
690		7	_aO31 - Innovation and Invention: Processes and Incentives _2Journal of Economic Literature class.
710	2		_aNational Bureau of Economic Research.
830		0	_aWorking Paper Series (National Bureau of Economic Research) _vno. w23900.
856	4	0	_uhttps://www.nber.org/papers/w23900
856			_yAcceso en línea al DOI _uhttp://dx.doi.org/10.3386/w23900
942			_2ddc _cW-PAPER
999			_c324223 _d282785